Table 3

In-hospital reperfusion and revascularisation strategies in the study patients

CharacteristicsTotal (n=1799)STEMI/new LBBB (n=463)UA/NSTEMI (n=1336)p Value
Reperfusion strategies, n (%)
 No reperfusion153 (33.6)
 Primary CABG13 (2.9)
 Thrombolytic therapy211 (46.3)
  Symptom onset to thrombolytic269.0±477.3
  Door-to-needle time45.6±41.1
 Primary PCI79 (17.3)
  Symptom onset to PCI256.8±186.6
  Door-to-balloon time82.8±112.5
Revascularisation strategies, n (%)
 Coronary angiography1232 (68.5)368 (79.5)864 (64.7)<0.0001
 PCI (excluding primary PCI)360 (20.0)133 (28.7)227 (17.0)<0.0001
  DES258 (71.9)94 (70.1)164 (72.9)0.764
  BMS81 (22.6)33 (24.6)48 (21.3)
  Both20 (5.5)7 (5.2)13 (5.8)
 CABG surgery180 (10.0)34 (7.3)146 (10.9)0.049
  • All plus-minus values are mean±SD.

  • BMS, bare metal stent; CABG, coronary artery bypass grafting surgery; DES, drug-eluting stent; LBBB, left bundle branch block; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; UA, unstable angina.